Scale up the supply of experimental Ebola drugs

Oliver Brady ()
Additional contact information
Oliver Brady: Oliver Brady is an epidemiologist at the University of Oxford, UK.

Nature, 2014, vol. 512, issue 7514, 233-233

Abstract: Estimates of the probable impact of the outbreak show that existing stocks of potentially useful medicines are insufficient, says Oliver Brady.

Date: 2014
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/512233a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:512:y:2014:i:7514:d:10.1038_512233a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/512233a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().